Skip to main content
All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q3 report for ABBOTT LABORATORIES on October 18, 2026, reporting $50,000 in lobbying income.

Lobbying for ABBOTT LABORATORIES · Medical Device and Healthcare Company.

All filings by TIBER CREEK GROUP · Everything ABBOTT LABORATORIES has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 18, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Illinois

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027; Issues pertaining to third party litigation funding; Issues pertaining to H.R. 8845 - Commerce, Justice, Science, and Related Appropriations Act.

Issues related to global health policy and funding.

 Bills named in this filing 2
  • H.R. 8595
    National Security, Department of State, and Related Programs Appropriations Act, 2027
  • H.R. 8845
    Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem